Zhuhai Rundu Pharmaceutical Co Ltd Class A - Asset Resilience Ratio

Latest as of March 2026: 0.00%

Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has an Asset Resilience Ratio of 0.00% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Zhuhai Rundu Pharmaceutical Co Ltd Class to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥49.70K

≈ $7.27K USD Cash + Short-term Investments

Total Assets

CN¥1.98 Billion

≈ $289.93 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how Zhuhai Rundu Pharmaceutical Co Ltd Class A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Zhuhai Rundu Pharmaceutical Co Ltd Class asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Zhuhai Rundu Pharmaceutical Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of Zhuhai Rundu Pharmaceutical Co Ltd Class for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥49.70K	0.0%
Total Liquid Assets	CN¥49.70K	0.00%

Asset Resilience Insights

Limited Liquidity: Zhuhai Rundu Pharmaceutical Co Ltd Class A maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhuhai Rundu Pharmaceutical Co Ltd Class A Industry Peers by Asset Resilience Ratio

Compare Zhuhai Rundu Pharmaceutical Co Ltd Class A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2020–2025)

The table below shows the annual Asset Resilience Ratio data for Zhuhai Rundu Pharmaceutical Co Ltd Class A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.00%	CN¥53.63K ≈ $7.85K	CN¥2.03 Billion ≈ $296.85 Million	0.00pp
2024-12-31	0.00%	CN¥65.71K ≈ $9.62K	CN¥2.19 Billion ≈ $321.00 Million	+0.00pp
2023-12-31	0.00%	CN¥52.23K ≈ $7.64K	CN¥2.23 Billion ≈ $325.99 Million	0.00pp
2022-12-31	0.00%	CN¥61.78K ≈ $9.04K	CN¥2.29 Billion ≈ $334.56 Million	0.00pp
2021-12-31	0.00%	CN¥86.77K ≈ $12.70K	CN¥1.91 Billion ≈ $279.41 Million	-2.90pp
2020-12-31	2.91%	CN¥44.01 Million ≈ $6.44 Million	CN¥1.51 Billion ≈ $221.51 Million	--

pp = percentage points

About Zhuhai Rundu Pharmaceutical Co Ltd Class A

SHE:002923 China Drug Manufacturers - Specialty & Generic

Market Cap

$537.10 Million

CN¥3.67 Billion CNY

Market Cap Rank

#11949 Global

#3437 in China

Share Price

CN¥10.96

Change (1 day)

+1.76%

52-Week Range

CN¥9.32 - CN¥17.35

All Time High

CN¥20.52